Komori
Mitani Sangyo (8285) · RiskMitigated

Decline in contract manufacturing revenue for functional ingredients due to lower demand for in-store sales in the health food sector

First written in FY2021-Q2. 3 of 7 entries say "Restated". Latest entry: FY2023.

7entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q2 – FY2021MitigatedFY2023-Q1 – FY2023-Q2RestatedFY2023-Q32020: 120202021: 220212022: 220222023: 22023
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023MitigatedAnnual report

    「In contract manufacturing of functional materials, sales increased as demand for in-store sales recovered because the impact of COVID-19 was less pronounced than in the previous fiscal year.」

    Demand for in-store sales of health foods and other products recovered, easing the risk of lower contract manufacturing revenue caused by the decline in demand.
  2. FY2023-Q3RestatedAnnual report

    「In contract manufacturing of functional materials, sales increased as demand for in-store sales recovered because the impact of COVID-19 was less pronounced than in the same period of the previous year.」

    Contract manufacturing revenue for functional materials continues to increase as demand for in-store sales of health foods and other products recovers.
  3. FY2023-Q2MitigatedAnnual report

    「In contract manufacturing of functional materials, sales increased as demand for in-store sales recovered because the impact of COVID-19 was less pronounced than in the same period of the previous year.」

    Demand for in-store sales in the health food sector and other areas recovered, easing the risk of lower contract manufacturing revenue for functional materials caused by the decline in demand.
  4. FY2023-Q1MitigatedAnnual report

    「In contract manufacturing of functional materials, sales increased as demand for in-store sales recovered because the impact of COVID-19 was less pronounced than in the same period of the previous year.」

    Demand for in-store sales in the health food sector recovered, easing the risk of lower contract manufacturing revenue for functional materials caused by the decline in demand.
  5. FY2021RestatedAnnual report

    「Revenue from contract manufacturing of functional materials declined due to the impact of lower in-store demand in the health food sector and other factors.」

    The decline in in-store demand in the health food sector was a factor behind the full-year decrease in revenue from contract manufacturing of functional materials.
  6. FY2021-Q3RestatedAnnual report

    「In contract manufacturing of functional materials, sales declined under the impact of lower demand for in-store sales in the health food sector.」

    The decline in in-store demand in the health food sector continues to be a factor behind the decrease in revenue from contract manufacturing of functional materials.
  7. FY2021-Q2First statedAnnual report

    「In contract manufacturing of functional materials, sales declined under the impact of lower demand for in-store sales in the health food sector.」

    The decline in in-store demand in the health food sector materialized and became a factor behind the decrease in revenue from contract manufacturing of functional materials.
Moved together

"Deepening Engagement with Existing Customers, Developing New Customers, and Expanding the Recycling Business" moved the same way as this thread, in the same document, in 3 of its 7 moves.

333332★123456
  1. ★This thread
  2. 1Deepening Engagement with Existing Customers, Developing New Customers, and Expanding the Recycling Business3×
  3. 2Complementary growth through contract manufacturing of functional materials and catalysts, and new businesses3×
  4. 3Expanding Orders for Non-Residential Properties in the Greater Tokyo and Hokuriku Regions3×
  5. 4Expansion of the JAXSON and HIDEO luxury brand businesses through the acquisition of blisspa japan as a subsidiary3×
  6. 5Weak operating rates at customers’ production lines3×
  7. 6Strengthening the New Product Development Structure and Enhancing Brand Awareness2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Mitani Sangyo's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Decline in contract manufacturing revenue for functional ingredients due to lower demand for in-store sales in the health food sector | MITANI SANGYO CO.,LTD. (8285) | Komori